The FDA has approved a prefilled syringe formulation of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) that allows patients to self-inject the medication.

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...